[1] Moher D, Tetzlaff J, Tricco AC, et al. Epidemiology and reporting characteristics of systematic reviews[J]. PLoS Med, 2007, 4(3): e78. [2] Mulrow CD. The medical review article: State of the science[J]. Ann Intern Med, 1987, 106(3): 485-488. [3] Dixon E, Hameed M, Sutherland F, et al. Evaluating meta-analyses in the general surgical literature: A critical appraisal[J]. Ann Surg, 2005, 241(3): 450-459. [4] Padhraig S, Fleming, Despina Koletsi, et al. Blinded by PRISMA: Are Systematic Reviewers Focusing on PRISMA and Ignoring Other Guidelines? [J]. PloS ONE, 2014, 9(5):e96407. [5] Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement, Quality of Reporting of Meta-analyses[J]. Lancet, 1999, 354(9193): 1896-1900. [6] Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statemnt[J]. PloS ONE, 2009, 6(7):e1000097. [7]Liberati A, Altman DG, Tetzlaff J, et al.The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration[J]. Ann Intern Med, 2009, 151(4):W65-94. [8]Beller EM, Glasziou PP, Altman DG,et al.PRISMA for Abstracts: reporting systematic reviews in journal and conference abstracts.PLoS Med, 2013, 10(4):e1001419. [9]Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement[J]. Syst Rev, 2015, 4:1. [10]Shamseer L, Moher D, Clarke,et al.Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation[J]. BMJ, 2015, 349:g7647. [11]Welch V, Petticrew M, Tugwell P, et al. PRISMA-Equity 2012 extension: reporting guidelines for systematic reviews with a focus on health equity[J]. PLoS Med, 2012, 9(10):e1001-333. [12]Stewart LA, Clarke M, Rovers M, et al. Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement[J]. JAMA, 2015, 313(16):1657-1665. [13]Hutton B, Salanti G, Caldwell DM, et al. The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations[J]. Ann Intern Med, 2015, 162(11):777-784. [14]王小琴,韦当,刘雅莉,等. PRISMA声明应用现状调查[J]. 中国循证医学杂志, 2014, 14(9):1160-1164. [15]Tao KM1, Li XQ, Zhou QH, et al. From QUOROM to PRISMA: a survey of high-impact medical journals' instructions to authors and a review of systematic reviews in anesthesia literature[J]. PLoS One, 2011, 6(11):e27611. [16]Wen J, Ren Y, Wang L, et al. The reporting quality of meta-analyses improves: a random sampling study[J]. J Clin Epidemiol, 2008, 61(8):770-775. [17]Delaney A, Bagshaw SM, Ferland A, et al. A systematic evaluation of the quality of meta-analyses in the critical careliterature[J]. Crit Care,2005, 9(5): R575-582 [18]Tunis AS, McInnes MD, Hanna R, et al. Association of study quality with completeness of reporting: have completeness of reporting and quality of systematic reviews and meta-analyses in major radiology journals changed since publication of the PRISMA statement? [J]. Radiology, 2013, 269(2):413-426. [19]Panic N, Leoncini E, de Belvis G,et al. Evaluation of the endorsement of the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement on the quality of published systematic review and meta-analyses[J]. PLoS One, 2013, 8(12):e83138. [20]Vandenbroucke JP, von Elm E, Altman DG,et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration[J]. PLoS Med, 2007, 4:e297.
|